Tigermed Completes Acquisition of Japanese CRO Micron
Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, today announces the completion of its acquisition of CRO company Micron,Inc.
July 29, 2025
by PRNewswire
Healthcare Holding Schweiz Acquires Effectum CH-Rep (Switzerland)
Healthcare Holding Schweiz AG has successfully completed the acquisition of Effectum CH-Rep AG.
March 17, 2025
by PR Newswire
Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
Azurity announced today the successful completion of its acquisition of Covis from existing investors.
March 14, 2025
by PR Newswire
Mérieux NutriSciences Completes Acquisition of Bureau Veritas' Food Testing Activities in Japan, Morocco, Southeast Asia, and South Africa
Mérieux NutriSciences acquires Bureau Veritas' food testing activities in multiple regions, strengthening its global presence in food testing.
February 4, 2025
by PharmaSources
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Telix completes the acquisition from ImaginAb, getting a drug pipeline and a biologics technology platform.
January 31, 2025
by PRNewswire
Pharmaceutical Business Progress in China and Worldwide (March)
Progress in Pharmaceutical Business at Home and Abroad (March)
May 12, 2023
by PharmaSources
Novotech Acquires European CRO, Strengthens Global Operations
The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has over 250 employees.
January 12, 2023
by PharmaSources
Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Expands Drug Development and FDA Regulatory Expertise
January 12, 2023
by PharmaSources
Sanofi completes acquisition of Amunix
Sanofi announced the completion of its acquisition of Amunix Pharmaceuticals, Inc, adding a promising pipeline of T-cell engagers and cytokine therapies. The acquisition also provides access to Amunix Pro-XTEN...
February 10, 2022
by WorldPharmaNews
A Look at 2021 Mergers and Acquisitions
The COVID-19 health crisis has introduced new dynamics in the global healthcare system while pushing leading pharmaceutical companies into investing more in research and development as others are enticed into mergers...
December 17, 2021
by SHEM OIRERE
CSL to acquire Switzerland’s Vifor Pharma for $11.7bn
CSL has signed a definitive agreement for the acquisition of all publicly held stakes of Switzerland-based Vifor Pharma in a deal worth $11.7bn (A$16.4bn) in cash.
December 16, 2021
by Pharmaceutical-Technology
Pfizer signs agreement to acquire Arena Pharmaceuticals for $6.7bn
Pfizer has signed a definitive agreement for the acquisition of all the outstanding shares of clinical-stage firm Arena Pharmaceuticals in a deal worth nearly $6.7bn or $100 for each share in cash.
December 15, 2021
by Pharmaceutical-Technology